Personal information

Activities

Collapse all

Employment (4)

King's College London: London, GB

Employment
Source: check_circle
King's College London

NIHR Clinical Research Network: London, GB

2010-09 to present | Paediatric Clinical Trial Pharmacist (Children)
Employment
Source: Self-asserted source
Mandy Wan

Guy's and Saint Thomas' NHS Foundation Trust: London, London, GB

2010-09 to present | Lead Paediatric Research Pharmacist (Pharmacy)
Employment
Source: Self-asserted source
Mandy Wan

Great Ormond Street Hospital: London, GB

2008 to 2010 | Clinical Research Facility Pharmacist (Clinical Research Facility)
Employment
Source: Self-asserted source
Mandy Wan

Education and qualifications (5)

King's College London: London, GB

2023 | Certificate (Postgraduate) - Applied Statistical Modelling and Health Informatics
Education
Source: Self-asserted source
Mandy Wan

King's College London: London, GB

2021 | PhD (Pharmaceutical Science)
Education
Source: Self-asserted source
Mandy Wan

University of Oxford: Oxford, Oxfordshire, GB

2011 | MSc - Experimental Therapeutic
Education
Source: Self-asserted source
Mandy Wan

University of Brighton: Brighton, East Sussex, GB

2005 | Diploma in clinical pharmacy
Education
Source: Self-asserted source
Mandy Wan

University of Nottingham: Nottingham, Nottingham, GB

2002 | MPharm - Pharmacy
Education
Source: Self-asserted source
Mandy Wan

Funding (10)

A randomised trial of aminophylline, magnesium sulfate or salbutamol intravenous therapy for acute severe asthma in children and young people.

2025-01-01 to 2027-12-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.14347610
GRANT_NUMBER: NIHR162027
Source: Self-asserted source
Mandy Wan via DimensionsWizard

DEXmedetomidine Trial of Adjunct Treatment with Morphine (DEXTA): a masked, randomised placebo-controlled trial

2024-11-01 to 2030-04-30 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.14073258
GRANT_NUMBER: NIHR158535
Source: Self-asserted source
Mandy Wan via DimensionsWizard

BAR-JDM: Baricitinib in Juvenile Dermatomyositis: A multi-centre open label, randomised, controlled, superiority trial

2024-06 to 2029-06 | Grant
Versus Arthritis (Chesterfield, GB)
GRANT_NUMBER:

23225
Source: Self-asserted source
Mandy Wan

NIHR Development and Skills Enhancement Award

2022-03 to 2023-02 | Award
National Institute for Health Research (London, Greater London, GB)
Source: Self-asserted source
Mandy Wan

A Phase II, randomised, single-blind, platform trial to assess safety, reactogenicity and immunogenicity of COVID-19 vaccines in pregnant women in the United Kingdom

2021-07 to 2024-10 | Grant
National Institute for Health Research (London, Greater London, GB)
Source: Self-asserted source
Mandy Wan

Prophylactic antibiotics to prevent chest infections in children with neurological impairment (Parrot) trial

2019-03 to 2024-02 | Grant
National Institute for Health Research (N/A, GB)
GRANT_NUMBER: 16/17/01
Source: Self-asserted source
Mandy Wan

What dose of vitamin D is required to achieve target serum 25-hydroxyvitamin D levels in children?

2017-04-01 to 2021-03-31 | Grant
National Institute for Health and Care Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.6954059
GRANT_NUMBER: ICA-CDRF-2016-02-057
Source: Self-asserted source
Mandy Wan via DimensionsWizard

The cystic fibrosis (CF) anti-staphylococcal antibiotic prophylaxis trial (CF START); a randomised registry trial to assess the safety and efficacy of flucloxacillin as a longterm prophylaxis agent for infants with CF

Source: Self-asserted source
Mandy Wan via DimensionsWizard

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia (CAP): a randomised controlled trial

2016-03 to 2019-10 | Grant
National Institute for Health Research (N/A, GB)
GRANT_NUMBER: 13/88/11
Source: Self-asserted source
Mandy Wan

Assessing the efficacy and safety of methotrexate vs ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema in children Taskforce (TREAT) randomised controlled trial

Source: Self-asserted source
Mandy Wan via DimensionsWizard

Peer review (2 reviews for 1 publication/grant)

Review activity for Pediatric nephrology. (2)
How many people are using ORCID?